ADMA Biologics Receives BioNJ 2020 Innovator Award for ASCENIV™

    NEXT STORY
    Ballad Health Reports FY20 Second Quarter Results
    PREV STORY
    Salarius Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Radius Health to Present Data on Abaloparatide at ASBMR 2019 Annual Meeting

    author_avatar
    NASDAQ Market News

    Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

    author_avatar
    NASDAQ Market News

    ContraVir Pharmaceuticals Appoints Two New Hepatitis B Experts to Scientific Advisory Board

    author_avatar
    NASDAQ Market News